THE IMPACT OF FERTILITY PRESERVATION PROGRAMS ON THE QUALITY OF LIFE OF WOMEN WITH ONCOLOGICAL DISEASES
Keywords:
cancer, fertility preservation, prognosis, quality of lifeAbstract
This study examines the impact of fertility preservation programs on the quality of life of women with oncological diseases. The study included 140 patients divided into two groups: the primary group (75 women who underwent fertility preservation programs) and the control group (65 women not participating in such programs). Quality of life was assessed using the FertiQOL questionnaire, which consists of four domains: emotional, social, physical, and mental well-being. The results showed that women in the primary group had significantly higher scores in all areas of quality of life compared to the control group (p < 0.001). Thus, fertility preservation programs positively affect the quality of life of these patients, highlighting the need for their implementation in a comprehensive approach to the treatment of cancer patients.
References
Boivin, J, Takefman, J, Braverman, A. (2011). The fertility quality of life (FertiQoL) tool: development and general psychometric properties. Human Reproduction, 26(8), 2084–2091.
Nurudeen S.K., Douglas N.C., Mahany E.L., Sauer M.V., Choi J.M. Fertility preservation decisions among newly diagnosed oncology patients: A single-center experience. Am. J. Clin. Oncol. 2016;39:154–159.
Balachandren N., Davies M. Fertility, ovarian reserve and cancer. Maturitas. 2017;105:64–68.
Stroud J.S., Mutch D., Rader J., Powell M., Thaker P.H., Grigsby P.W. Effects of cancer treatment on ovarian function. Fertil. Steril. 2009;92:417–427.
Mahajan N. Fertility preservation in female cancer patients: An overview. J. Hum. Reprod. Sci. 2015;8:3–13.
Arbyn M., Weiderpass E., Bruni L., de Sanjosé S., Saraiya M., Ferlay J., Bray F. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob. Health. 2020;8:e191–e203.
Alimjanovich , R. Z., Maxammatkulovich , R. N., & Khikmatovich , K. K. (2022). Age Features of the Prevalence of Prostate Cancer in Uzbekistan. Central Asian Journal of Medical and Natural Science, 3(5), 154-157. Retrieved from
Rizaev Jasur , Rakhimov Nodir , Kodyrov Khamidullo , Shakhanova Shakhnoza . Study of prostate cancer death by regions of the republic of Uzbekistan.Journal of Biomedicine and Practice. 2022, vol . 7, issue 5, pp.202-210
Nodir RM, Shaxnoza SS, Farhod R. Development of new approaches in the treatment of metastatic renal cell carcinoma //Journal of research in health science. – 2020. – T. 5. – no. 4. – pp. 82-95.
ShSh Shakhanova , NM Rakhimov. Multimodal approach to the treatment of multiple osteogenic metastases of kidney and prostate cancer . Clinical and Experimental Oncology 2020, No. 4 Page 50-56.
Guillon S., Popescu N., Phelippeau J., Koskas M. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma. Int. J. Gynaecol. Obstet. 2019;146:277–288.
